Role of nucleophosmin in embryonic development and tumorigenesis
Top Cited Papers
- 6 July 2005
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 437 (7055) , 147-153
- https://doi.org/10.1038/nature03915
Abstract
Nucleophosmin is an oestrogen-regulated nucleolar protein that has been implicated in a number of cancers including myelodysplastic syndromes (MDS), a group of diseases characterized by overproduction of blood cells in the bone marrow. Now a role for nucleophosmin has been identified in normal cells: it is essential for normal embryonic development and, specifically, for the control of centrosome duplication and genomic stability. Loss of the Npm1 gene in mice produces features similar to those seen in MDS patients. Nucleophosmin (also known as NPM, B23, NO38) is a nucleolar protein directly implicated in cancer pathogenesis, as the NPM1 gene is found mutated and rearranged in a number of haematological disorders1,2,3,4,5. Furthermore, the region of chromosome 5 to which NPM1 maps is deleted in a proportion of de novo human myelodysplastic syndromes (MDS)6,7,8,9, and loss of chromosome 5 is extremely frequent in therapy-related MDS9,10. NPM is a multifunctional protein11,12,13,14,15, and its role in oncogenesis is controversial as NPM has been attributed with both oncogenic and tumour suppressive functions16,17,18,19. To study the function of Npm in vivo, we generated a hypomorphic Npm1 mutant series (Npm1+/- < Npm1hy/hy < Npm1-/-) in mouse. Here we report that Npm is essential for embryonic development and the maintenance of genomic stability. Npm1-/- and Npm1hy/hy mutants have aberrant organogenesis and die between embryonic day E11.5 and E16.5 owing to severe anaemia resulting from defects in primitive haematopoiesis. We show that Npm1 inactivation leads to unrestricted centrosome duplication and genomic instability. We demonstrate that Npm is haploinsufficient in the control of genetic stability and that Npm1 heterozygosity accelerates oncogenesis both in vitro and in vivo. Notably, Npm1+/- mice develop a haematological syndrome with features of human MDS. Our findings uncover an essential developmental role for Npm and implicate its functional loss in tumorigenesis and MDS pathogenesis.Keywords
This publication has 28 references indexed in Scilit:
- Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its FunctionMolecular and Cellular Biology, 2005
- Hypoxia-induced Nucleophosmin Protects Cell Death through Inhibition of p53Journal of Biological Chemistry, 2004
- B23/Nucleophosmin Serine 4 Phosphorylation Mediates Mitotic Functions of Polo-like Kinase 1Journal of Biological Chemistry, 2004
- Myelodysplastic SyndromesHematology-American Society Hematology Education Program, 2004
- Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31Leukemia, 2003
- UV Stimulation of Nucleophosmin/B23 Expression Is an Immediate-early Gene Response Induced by Damaged DNAJournal of Biological Chemistry, 2002
- Mapping the Functional Domains of Nucleolar Protein B23Journal of Biological Chemistry, 2000
- Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activityOncogene, 1997
- 5q-, twenty-five years later: a SynopsisCancer Genetics and Cytogenetics, 1997
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994